E0 ConsensusPreliminaryPEM unclearSystematic-ReviewPeer-reviewedReviewed
A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID).
Corbitt, Matthew, Eaton-Fitch, Natalie, Staines, Donald et al. · BMC neurology · 2019 · DOI
Quick Summary
Researchers reviewed 15 studies that measured immune signaling molecules called cytokines in people with ME/CFS compared to healthy people. Although many studies have looked at cytokines in ME/CFS, the results were too mixed and inconsistent to show that cytokines could be used as a reliable test for the condition or to confirm a clear role in causing the disease.
Why It Matters
Identifying reliable biomarkers is critical for ME/CFS diagnosis and treatment development, as the condition currently lacks objective diagnostic tests. This review reveals that while cytokine research is active, the field has not yet produced consistent enough evidence to move cytokines into clinical use, highlighting the need for more rigorous, standardized research approaches.
Observed Findings
- 15 studies met inclusion criteria after screening 16,702 publications
- All included studies were observational case-control designs
- Ten studies measured serum cytokines; four measured cytokines in other physiological fluids
- Most included studies demonstrated consistent methodology and moderate quality
- Findings across studies were too heterogeneous to reach definitive conclusions about cytokine differences
Inferred Conclusions
- Cytokines cannot currently serve as reliable biomarkers for ME/CFS diagnosis
- Despite moderate quality evidence, available research is inconclusive regarding whether cytokines play a definitive pathological role in ME/CFS
- Further research using standardized methodologies is needed to clarify cytokine involvement in the disease
Remaining Questions
- What methodological standardization is needed across cytokine studies to produce consistent, comparable results?
- Are specific cytokine profiles or combinations more relevant to ME/CFS pathology than individual cytokine measurements?
- Could longitudinal studies tracking cytokine changes over time reveal patterns that cross-sectional studies miss?
What This Study Does Not Prove
This review does not prove that cytokines play no role in ME/CFS—only that current evidence is too inconsistent to establish them as reliable diagnostic markers. It also does not identify which specific cytokines, if any, are meaningfully altered in ME/CFS, nor does it establish causative relationships between cytokine abnormalities and disease symptoms.
Tags
Method Flag:PEM_UNCLEARWeak Case DefinitionMixed Cohort
Symptom:Fatigue
Biomarker:CytokinesBlood Biomarker
Metadata
- DOI
- 10.1186/s12883-019-1433-0
- PMID
- 31445522
- Review status
- Editor reviewed
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 7 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.